Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?

A healthcare social media research article published in Current Hematologic Malignancy Reports, October 23, 2017

Title
Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?
Authors (alpha)
Aaron T. Gerds, Teresa Chan
Published
October 23, 2017
Journal
Current Hematologic Malignancy Reports
Impact Factor
2.2
DOI
10.1007/s11899-017-0424-8
Pubmed
29064027
Altmetric
A healthcare social media research article published in Current Hematologic Malignancy Reports, October 23, 2017

Abstract

Social media is becoming a crucial part of our society. While the field of medicine has lagged behind in adopting and harnessing these platforms, we are now starting to see a surge in social media usage for medical education and scientific communication (e.g., knowledge translation, research collaboration, discussion, and discourse). Over the course of this review, we aim to update the reader on the way in which Twitter and other social media platforms may be used in hematology for research ideas, collaboration, and scholarly activity. Twitter use has grown exponentially over the past decade and is now woven into the fabric of modern communication. It can be a useful tool for those who wish to engage both colleagues and the public. While some issues such as reporting of financial conflict of interest still need to be addressed, Twitter, and social medial in general, can be a powerful instrument for researchers, educators, patients, and advocacy groups.


Altmetric

The Altmetric Attention Score is based on the attention a research article gets on the internet. Each coloured thread in the circle represents a different type of online attention and the number in the centre is the Altmetric Attention Score. The score is calculated based on two main sources of online attention: social media and mainstream news media.

Healthcare Social Media Research

See the full list of healthcare social media research articles with data from or reference to Symplur.
#hcsmR is a collaboration between Stanford Medicine X and Symplur.